UCL Department of Biochemical Engineering


Vax Hub Platform Funding

Call for proposals for feasibility studies has now closed

Feasibility Studies Funding 

The deadline for the submission of applications for funding of up to £100,000 to support feasibility studies has now passed.

Funding will be awarded in September 2020.

Vax-Hub is pleased to announce the award of interaction vouchers to support the following collaborative activity.

PartnersProject title
Hilleman Labs & UCLEstablishing the use of microscale chromatography-for downstream process optimization of Group B streptococcus polysaccharides
Phenotypeca Ltd and the University of OxfordExploiting the genetic diversity of Saccharomyces cerevisiae for VLP production
Sartorius Stedim Biotech and the University of OxfordCost of goods evaluation of adenovirus-based vaccine against Coronavirus
Sartorius Stedim Biotech and the University of OxfordImproving scalability and productivity of an adenovirus-based vaccine against Coronavirus
Univercells, University of Leeds & UCLProof of principle synthesis of polio virus-like particles in an E. coli cell-free manufacturing platform
Vironova and UCLMiniTEM analysis: characterisation of Viral Vaccines, Vectors and VLPs

Vax-Hub membership

Platform funding will be awarded to members* of the Vax-Hub Users Group only.  If you are not currently a member of the Hub but would be interested in joining to access this and other Hub benefits, please contact Jane Doogan, Vax-Hub Project Manager: j.doogan@ucl.ac.uk